Reuters |
EU approves Sanofi and Regeneron's dupilumab in eczema – Reuters
Reuters The European Commission approved Regeneron Pharmaceuticals' and Sanofi's key biologic treatment dupilumab for moderate-to-severe atopic dermatitis, the … Sanofi's Dupixent gets Europe eczema nod Sanofi, Regeneron claim EU approval for eczema drug Dupixent Regeneron and Sanofi Announce Approval of DUPIXENT® (dupilumab) to Treat Adult Patients with Moderate-to … |
